Original data · 2026-06-04
Semaglutide Price Report — June 2026
Tracked averages of published online semaglutide pricing, with what changed since last month. Every value links to a dated source-archive entry.
Quick Answer
This report summarizes the published online semaglutide prices we tracked this month. All figures are placeholders until populated from verified, dated source entries — we do not publish report numbers we have not checked.
| Metric | This month | Change |
|---|---|---|
| Average published monthly price | verify | — |
| Lowest advertised starter | verify | — |
| Lowest bundled monthly plan | verify | — |
| Highest branded cash-pay | verify | — |
| Providers with unclear dose pricing | verify | — |
Regulatory update
Summarize the current FDA compounding status here with a dated source. As of 2026-06-04, the FDA’s April 2026 proposal to remove semaglutide from the 503B bulks list remains a live development — link the primary source.
Bottom Line
Use this report for direction over time. For your own cost, run your provider’s figures through the calculator.
Compounded semaglutide is not FDA-approved as a finished drug product. Compounded medications may be prescribed only when clinically appropriate and must be evaluated by a licensed prescriber. Branded medications such as Wegovy and Ozempic are FDA-approved products; compounded semaglutide is different and should not be described as FDA-approved, “generic Wegovy,” or “generic Ozempic.”